Advances in Melanoma: From Biology to Therapy

黑色素瘤的进展：从生物学到治疗

• 批准号: 8785875
• 负责人: Margaret Foti
• 金额: $ 0.4万
• 依托单位: AMERICAN ASSOCIATION FOR CANCER RESEARCH
• 依托单位国家: 美国
• 财政年份: 2014
• 资助国家: 美国
• 起止时间: 2014-08-06 至 2015-07-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/8785875
• 关键词: Academia; Address; Basic Science; Biology; Clinic; Clinical; Combined Modality Therapy; Communities; Development; Drug resistance; Epigenetic Process; Fostering; Genetic; Goals; Hour; Industry; Knowledge; Learning; Minor; Participant; Pathogenesis; Philadelphia; Physicians; Research; Research Personnel; Resistance; Scientist; Skin Cancer; Students; Therapeutic; Time; Translating; Translational Research; Work; advanced disease; clinical practice; effective therapy; melanoma; novel; novel strategies; novel therapeutic intervention; peer; posters; public health relevance; response; symposium; therapy resistant

DESCRIPTION (provided by applicant): The proposed conference, titled "Advances in Melanoma: From Biology to Therapy," will be held from September 20-23, 2014 at the Loews Philadelphia, Philadelphia, PA. This special conference will address the unique issues and challenges in investigating and effectively treating melanoma. The goal of this conference is to bring together the top basic, translational, and clinical researchers in the field to discuss how basic research findings can be translated effectively into novel treatment options in the clinic. Scientific sessions will consist of seven presentations in major session (four hours) and three presentations in minor (two hours) sessions from expert researchers. Each presentation from expert researchers will be 20-25 minute presentations long. Additionally, to encourage young investigators one to two proffered short talk 15-20 minute will be incorporated in each session with ample time for discussion. Conference will start with presentations covering the advances in genetics, epigenetics, pathogenesis of melanoma biology, leading the discussion into principles of response and resistance to therapy-currently a major problem, concluding the discussion on emerging new strategies of using combination therapy. A special one-hour panel discussion will focus on challenges and opportunities in the melanoma research. Poster sessions will be held to allow investigators to present and discuss their latest research in an informal setting. This conference will appeal to investigators focused on the basic, translational, and clinical aspects of melanoma and will foster collaborative interdisciplinary interactions to stimulate the development of new research and clinical practices. It is expected that this new conference will provide a unique forum for discussions that will further the basic, translational, and clinical goals of the field.

描述（由申请人提供）：拟议的会议题为“黑色素瘤的进展：从生物学到治疗”，将于 2014 年 9 月 20 日至 23 日在宾夕法尼亚州费城的洛斯费城举行。这次特别会议将讨论调查和有效治疗黑色素瘤的独特问题和挑战。本次会议的目标是汇集该领域顶尖的基础、转化和临床研究人员，讨论如何将基础研究成果有效转化为临床的新型治疗方案。科学会议将包括专家研究人员在主要会议（四小时）中的七次演讲和在次要会议（两小时）中的三场演讲。专家研究人员的每次演讲长度为 20-25 分钟。此外，为了鼓励年轻研究者，每次会议将提供一到两个 15-20 分钟的简短谈话，并有充足的讨论时间。会议将以涵盖遗传学、表观遗传学、黑色素瘤生物学发病机制进展的演讲开始，引导讨论目前的主要问题——治疗反应和耐药性的原理，最后讨论使用联合治疗的新兴新策略。为期一小时的特别小组讨论将重点讨论黑色素瘤研究中的挑战和机遇。将举行海报会议，以便研究人员在非正式场合展示和讨论他们的最新研究。这次会议将吸引关注基础、转化、 和黑色素瘤的临床方面，并将促进跨学科的协作互动，以刺激新研究和临床实践的发展。预计这次新会议将提供一个独特的讨论论坛，以进一步推进该领域的基本、转化和临床目标。